Background: This study aimed to determine the correlation of plasma asprosin with anthropometric and metabolic parameters in Korean children and adolescents.
Methods: This single-center study included 109 Korean children and adolescents: 62 (56.9%) obese participants with a body mass index (BMI) ≥95th percentile and 47 (43.1%) healthy controls with BMI between the 15th and 85th percentile. Metabolic parameters were measured, including fasting blood glucose, fasting insulin, homeostasis model assessment of insulin resistance (HOMA-IR), triglyceride and glucose (TyG) index, and lipid profiles.
Results: Plasma asprosin levels were higher in the obese group than in the control group (mean 87.0 vs. 69.3 ng/mL; = 0.001) and in the IR group than in the non-IR group (mean 98.6 vs. 70.2 ng/mL; < 0.001). Plasma asprosin levels were not associated with sex or pubertal stage. Plasma asprosin levels were positively correlated with BMI SDS ( = 0.34; = 0.002), glycated hemoglobin (HbA1c) ( = 0.25; = 0.02), glucose ( = 0.33; = 0.002), insulin ( = 0.44; < 0.001), HOMA-IR ( = 0.47; < 0.001), triglyceride (TG) ( = 0.33; = 0.003), high-density lipoprotein (HDL) cholesterol ( = -0.29; = 0.008), and TyG index ( = 0.38; < 0.001). Multiple linear regression analysis indicated that plasma asprosin levels were independently associated with HOMA-IR ( < 0.001) and TG/HDL cholesterol ratio ( < 0.001).
Conclusions: This study demonstrated an association between plasma asprosin levels and obesity and insulin resistance in Korean children and adolescents.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11484027 | PMC |
http://dx.doi.org/10.3389/fendo.2024.1452277 | DOI Listing |
Front Endocrinol (Lausanne)
October 2024
Department of Pediatrics, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Background: This study aimed to determine the correlation of plasma asprosin with anthropometric and metabolic parameters in Korean children and adolescents.
Methods: This single-center study included 109 Korean children and adolescents: 62 (56.9%) obese participants with a body mass index (BMI) ≥95th percentile and 47 (43.
J Diabetes Investig
December 2024
Department of Endocrinology, First Hospital of Shanxi Medical University, Shanxi Medical University, Taiyuan, Shanxi, China.
Aims/introduction: To investigated the association between serum asprosin and metabolic characteristics in type 2 diabetes mellitus patients with different durations.
Materials And Methods: A total of 436 patients with type 2 diabetes mellitus were enrolled in this study from the community health service center in southeastern Shanxi Province. All the patients were divided into two groups according to their diabetes duration: diabetes duration ≤5 years group (n = 132) and diabetes duration ≥10 years group (n = 304).
Eur Rev Med Pharmacol Sci
August 2024
Department of Cardiology, Cardiology Clinic, Gaziantep City Hospital, Gaziantep, Turkey.
Objective: Sodium-glucose co-transporter-2 inhibitors (SGLT-2i) are a new class of drugs that lower blood glucose and reduce mortality in heart failure patients with reduced ejection fraction (HFrEF). They also have antioxidant effects. The exact mechanism of SGLT-2i is unknown.
View Article and Find Full Text PDFIr J Med Sci
December 2024
College of Education for Pure Science (IbnAl-Haitham), University of Baghdad, Baghdad, Iraq.
Background: Double diabetes is a term used to describe people with type 1 diabetes who are overweight, show signs of insulin resistance, or have a family history of type 2 diabetes. Asprosin is a novel glucogenic adipokine; Asprosin regulates appetite and glucose metabolism. The study aimed to investigate the level of asprosin in people with double diabetes with and without hypothyroidism and its association with markers of insulin resistance.
View Article and Find Full Text PDFDiabetes Metab Syndr Obes
June 2024
Department of Endocrinology, Translational Research of Diabetes Key Laboratory of Chongqing Education Commission of China, Second Affiliated Hospital of Army Medical University, Chongqing, People's Republic of China.
Purpose: To explore the expression of asprosin in subjects with pre-DKD and DKD and to analyze its relationship with kidney injury, inflammation, and glucose and lipid metabolism.
Methods: Based on urine albumin:creatinine ratio (UACr), participants were divided into DM, pre-DKD, and DKD groups. Relevant human physiological and biochemical parameters were detected in the three groups.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!